ProQuest Financial LLC, 10% Owner at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 83,079 shares at $60.78 ($5.1M) on 2016-08-16, disclosed to the SEC on 2016-08-17.
Open-market sale of $5.1M EGRX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.70 | 163 | $10K | 0.2% |
| 2 | $61.31 | 8,070 | $495K | 9.7% |
| 3 | $60.66 | 16,270 | $987K | 19.3% |
| 4 | $60.78 | 117 | $7K | 0.1% |
| 5 | $60.78 | 394 | $24K | 0.5% |
| 6 | $61.65 | 11,770 |
| $726K |
| 14.2% |
| 7 | $62.21 | 31,599 | $2.0M | 38.5% |
| 8 | $60.85 | 4,723 | $287K | 5.6% |
| 9 | $61.00 | 29 | $2K | 0.0% |
| 10 | $61.00 | 96 | $6K | 0.1% |
| 11 | $61.19 | 9,848 | $603K | 11.8% |
| Total | $61.53 avg | 83,079 | $5.1M | 100% |
| Filing → |